Your Source for Venture Capital and Private Equity Financings

Venture Capital News: Differentiated Therapeutics Inks $5M Seed Round

2022-08-01
CAMBRIDGE, MA, Differentiated Therapeutics (dx/tx), a biotech company, announced the completion of a $5 million Seed financing from Curie.Bio.
Differentiated Therapeutics (dx/tx), a biotech company focused on computationally predicting and optimizing targeted protein degraders (TPDs), announced the completion of a $5 million Seed financing. Curie.Bio, a founder-focused seed-stage venture capital firm, financed the round.

Differentiated Therapeutics' mission is to design and develop disease-modifying TPD therapies for patients with unmet medical need. Founded in 2021 by leaders in small molecule and AI-driven drug discovery, the company is based in San Diego, CA and Cambridge, MA.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors